Oaklins’ team in Russia will join SFM Group at the BIO 2017

Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections, regenerative medicines, etc. Its breakthrough product is Trombovazim, a powerful thrombolytic with a very high bio-accessibility created using Axis technology, an innovative medicine that has no comparable drugs in the world’s pharma market.

The BIO International Convention is the largest global event for the biotechnology industry that attracts the leading companies in biotech, offering key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.